Summary

• There is a high prevalence and incidence of erectile dysfunction worldwide, and screening should take place as part of routine health assessment.
• May be associated with established cardiovascular risk factors or be a precursor to significant cardiovascular, psychological, or endocrine disease.
• Treatment using oral phosphodiesterase-5 inhibitors is the mainstay of therapy.
• Complex patients and treatment failures should be evaluated by a urologist if continued therapy is desired.